| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |